Fangusaro JR, Onar-Thomas A, Poussaint TY, Wu S, et al. Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. Neuro Oncol 2022 Mar 21. pii: 6551018. doi: 10.1093.
PMID: 35307742